Trials / Completed
CompletedNCT03841331
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 233 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5 mg Serlopitant Tablets | Serlopitant Tablets |
| DRUG | Matching Placebo Tablets | Placebo Tablets |
Timeline
- Start date
- 2019-01-22
- Primary completion
- 2019-12-10
- Completion
- 2020-01-21
- First posted
- 2019-02-15
- Last updated
- 2021-05-20
- Results posted
- 2020-09-23
Locations
41 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03841331. Inclusion in this directory is not an endorsement.